Gator Bio

Biomolecular analysis using BLI technology

Palo Alto, California, United States

About Gator Bio

Gator Bio focuses on biomolecular analysis using Biolayer Interferometry (BLI) technology, which allows researchers to study molecular interactions with high sensitivity. Their products include reusable biosensors and BLI instruments that assist in drug development and various molecular research applications. Gator Bio stands out by serving a diverse clientele in the life sciences and biotechnology sectors, providing detailed insights that help accelerate research processes. The company's goal is to enhance scientific research and drug development through effective tools and support.

Palo Alto, CaliforniaHeadquarters
2017Year Founded
VENTURE_UNKNOWNCompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
401(k) Company Match
Paid Vacation
Paid Holidays

Risks

Emerging competition from Sartorius and FortéBio may impact Gator Bio's market share.
Rapid technological advancements could render Gator Bio's offerings obsolete without innovation.
Supply chain vulnerabilities in semiconductor components could disrupt Gator Bio's production.

Differentiation

Gator Bio specializes in biomolecular analysis using advanced Biolayer Interferometry technology.
Their BLI technology offers high sensitivity and precision in studying molecular interactions.
Gator Bio serves diverse clients, including pharmaceutical companies and academic institutions.

Upsides

Increased demand for high-throughput screening benefits Gator Bio's BLI product offerings.
AI integration enhances precision and speed, boosting Gator Bio's technology value.
Rising collaborations with academic institutions expand Gator Bio's client base.